This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.
Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.


This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.

Are you a healthcare professional?

Speaker - Salvatore Petta
University of Palermo, Palermo, Italy

Salvatore Petta obtained Degree in Medicine at the University of Palermo on July 2002, and then at the same University he became a Specialist in Gastroenterology on December 2006, PhD on Biopathology on March 2010, and Associate Professor of Gastroenterology since November 2019.


Dr Petta was/is principal-investigator in different clinical trials on chronic hepatitis C and Non-alcoholic steatohepatitis. He is the author of more than 200 peer-reviewed papers published in international journals.


He was Secretary of AISF (Italian association for the study of the liver) and member of EASL. His main areas of clinical and research interest are viral hepatitis and non-alcoholic fatty liver disease. He was speaker at different national and international scientific meetings, also acts as a reviewer for the EASL International Liver Congress, and as referee of papers published in international journals, and also acts as an associate editor for Liver International. He participated in writing 2021 European guidelines on noninvasive tests in chronic liver diseases, and 2021 Italian guidelines on management of Nonalcoholic fatty liver disease.